Abstract
Myocilin is secreted from trabecular meshwork cells to an eponymous extracellular matrix that is critical for maintaining intraocular pressure. Missense mutations found in the myocilin olfactomedin domain (OLF) lead to intracellular myocilin misfolding and are causative for the heritable form of early-onset glaucoma. The OLF domain contains a unique internal, hetero-dinuclear calcium site. Here, we tested the hypothesis that calcium dysregulation causes wild-type (WT) myocilin misfolding reminiscent of that observed for disease variants. Using two cellular models expressing WT myocilin, we show that the Ca2+ ATPase channel blocker thapsigargin inhibits WT myocilin secretion. Intracellular WT myocilin is at least partly insoluble and aggregated in the endoplasmic reticulum (ER), and stains positively with an amyloid dye. By comparing the effect of thapsigargin on WT myocilin to that on a de novo secretion-competent Ca2+-free variant D478S, we discern that non-secretion of WT myocilin is due initially to calcium dysregulation, and is potentiated further by resultant ER stress. In E. coli, depletion of calcium leads to recombinant expression of misfolded isolated WT OLF but the D478S variant is still produced as a folded monomer. Treatment of cells expressing a double mutant composed of D478S and either disease variants P370L or Y437H with thapsigargin promotes its misfolding and aggregation, demonstrating the limits of D478S to correct secretion defects. Taken together, the heterodinuclear calcium site is a liability for proper folding of myocilin. Our study suggests a molecular mechanism by which WT myocilin misfolding may contribute broadly to glaucoma-associated ER stress.
Graphical abstract
This study explores the effect of calcium depletion on myocilin olfactomedin domain folding.
Similar content being viewed by others
References
Donegan RK, Hill SE, Turnage KC, Orwig SD, Lieberman RL (2012) J Biol Chem 287:43370–43377
Polansky JR, Fauss DJ, Chen P, Chen H, Lütjen-Drecoll E, Johnson D, Kurtz RM, Ma ZD, Bloom E, Nguyen TD (1997) Ophthalmologica 211:126–139
Nguyen TD, Chen P, Huang WD, Chen H, Johnson D, Polansky JR (1998) J Biol Chem 273:6341–6350
Stone EM, Fingert JH, Wallace LMA, Nguyen TD, Polansky JR, Sara LFS, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC (1997) Science 275:668–670
Kwon YH, Fingert JH, Kuehn MH, Alward WLM (2009) N Engl J Med 360:1113–1124
Alvarado J, Murphy C, Juster R (1984) Ophthalmology 91:564–579
Rohen JW, Lutjen-Drecoll E, Flugel C, Meyer M, Grierson I (1993) Exp Eye Res 56:683–692
Peters JC, Bhattacharya S, Clark AF, Zode GS (2015) Invest Ophthalmol Vis Sci 56:3860–3868
Sears NC, Boese EA, Miller MA, Fingert JH (2019) Exp Eye Res 186:107702
Wiggs JL, Pasquale LR (2017) Hum Mol Genet 26:R21–R27
Scelsi HF, Barlow BM, Saccuzzo EG, Lieberman RL (2021) Hum Mutat 42:903–946
Donegan RK, Hill SE, Freeman DM, Nguyen E, Orwig SD, Turnage KC, Lieberman RL (2015) Hum Mol Genet 24:2111–2124
Stoilova D, Child A, Brice G, Desai T, Barsoum-Homsy M, Ozdemir N, Chevrette L, Adam MF, Garchon HJ, Pitts-Crick R, Sarfarazi M (1998) J Med Genet 35:989–992
Kennan AM, Mansergh FC, Fingert JH, Clark T, Ayuso C, Kenna PF, Humphries P, Farrar GJ (1998) J Med Genet 35:957–960
Campos-Mollo E, Sánchez-Sánchez F, López-Garrido MP, López-Sánchez E, López-Martínez F, Escribano J (2007) Mol Vis 13:1666–1673
Hill SE, Kwon MS, Martin MD, Suntharalingam A, Hazel A, Dickey CA, Gumbart JC, Lieberman RL (2019) J Biol Chem 294:12717–12728
Jacobson N, Andrews M, Shepard AR, Nishimura D, Searby C, Fingert JH, Hageman G, Mullins R, Davidson BL, Kwon YH, Alward WL, Stone EM, Clark AF, Sheffield VC (2001) Hum Mol Genet 10:117–125
Liu Y, Vollrath D (2004) Hum Mol Genet 13:1193–1204
Gobeil S, Rodrigue MA, Moisan S, Nguyen TD, Polansky JR, Morissette J, Raymond V (2004) Invest Ophthalmol Vis Sci 45:3560–3567
Suntharalingam A, Abisambra JF, O’Leary JC 3rd, Koren J 3rd, Zhang B, Joe MK, Blair LJ, Hill SE, Jinwal UK, Cockman M, Duerfeldt AS, Tomarev S, Blagg BS, Lieberman RL, Dickey CA (2012) J Biol Chem 287:40661–40669
Yam GH, Gaplovska-Kysela K, Zuber C, Roth J (2007) Am J Pathol 170:100–109
Joe MK, Sohn S, Hur W, Moon Y, Choi YR, Kee C (2003) Biochem Biophys Res Commun 312:592–600
Orwig SD, Perry CW, Kim LY, Turnage KC, Zhang R, Vollrath D, Schmidt-Krey I, Lieberman RL (2012) J Mol Biol 421:242–255
Hill SE, Donegan RK, Lieberman RL (2014) J Mol Biol 426:921–935
Gould DB, Reedy M, Wilson LA, Smith RS, Johnson RL, John SW (2006) Mol Cell Biol 26:8427–8436
Wiggs JL, Vollrath D (2001) Arch Ophthalmol 119:1674–1678
Tallapragada DS, Bhaskar S, Chandak GR (2015) Front Genet 6:251
Craig JE, Han X, Qassim A, Hassall M, Cooke-Bailey JN, Kinzy TG, Khawaja AP, An J, Marshall H, Gharahkhani P, Igo RP Jr, Graham SL, Healey PR, Ong JS, Zhou T, Siggs O, Law MH, Souzeau E, Ridge B, Hysi PG, Burdon KP, Mills RA, Landers J, Ruddle JB, Agar A, Galanopoulos A, White AJR, Willoughby CE, Andrew NH, Best S, Vincent AL, Goldberg I, Radford-Smith G, Martin NG, Montgomery GW, Vitart V, Hoehn R, Wojciechowski R, Jonas JB, Aung T, Pasquale LR, Cree AJ, Sivaprasad S, Vallabh NA, Consortium N, Eye UKB, Vision C, Viswanathan AC, Pasutto F, Haines JL, Klaver CCW, van Duijn CM, Casson RJ, Foster PJ, Khaw PT, Hammond CJ, Mackey DA, Mitchell P, Lotery AJ, Wiggs JL, Hewitt AW, MacGregor S (2020) Nat Genet 52:160–166
Stothert AR, Suntharalingam A, Huard DJ, Fontaine SN, Crowley VM, Mishra S, Blagg BS, Lieberman RL, Dickey CA (2014) Hum Mol Genet 23:6470–6480
Mekahli D, Bultynck G, Parys JB, De Smedt H, Missiaen L (2011) Cold Spring Harb Perspect Biol 2011:3
Hill SE, Donegan RK, Nguyen E, Desai TM, Lieberman RL (2015) PLoS ONE 10:e0130888
Zeng LC, Han ZG, Ma WJ (2005) FEBS Lett 579:5443–5453
Putignano V, Rosato A, Banci L, Andreini C (2018) Nucleic Acids Res 46:D459–D464
Liao J, Marinelli F, Lee C, Huang Y, Faraldo-Gomez JD, Jiang Y (2016) Nat Struct Mol Biol 23:590–599
Joe MK, Tomarev SI (2010) Am J Pathol 176:2880–2890
Lytton J, Westlin M, Hanley MR (1991) J Biol Chem 266:17067–17071
Shen D, Coleman J, Chan E, Nicholson TP, Dai L, Sheppard PW, Patton WF (2011) Cell Biochem Biophys 60:173–185
Burns JN, Orwig SD, Harris JL, Watkins JD, Vollrath D, Lieberman RL (2010) ACS Chem Biol 5:477–487
Clapham DE (2007) Cell 131:1047–1058
Berridge MJ, Bootman MD, Roderick HL (2003) Nat Rev Mol Cell Biol 4:517–529
Braakman I, Bulleid NJ (2011) Annu Rev Biochem 80:71–99
Lieberman RL, Ma MT (2021) Acc Chem Res 54:2205–2215
Oslowski CM, Urano F (2011) Methods Enzymol 490:71–92
Casanova D, Alemany P, Bofill JM, Alvarez S (2003) Chemistry 9:1281–1295
Kopec KO, Lupas AN (2013) PLoS ONE 8:e77074
Robinson PJ, Kanemura S, Cao X, Bulleid NJ (2020) J Biol Chem 295:2438–2448
Ricard CS, Tamm ER (2005) Exp Eye Res 81:501–502
Manders EMM, Verbeek FJ, Aten JA (1993) J Microsc 169:375–382
Bolte S, Cordelieres FP (2006) J Microsc 224:213–232
Acknowledgements
We thank Sara Bahri for technical assistance. This study was supported by NIH R01EY021205 and R21EY031093. EGS was supported in part by GAANN P200A210014, MDM was supported in part by 3R01EY021205-10S1, and MTM was supported by T32EY007092.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Saccuzzo, E.G., Martin, M.D., Hill, K.R. et al. Calcium dysregulation potentiates wild-type myocilin misfolding: implications for glaucoma pathogenesis. J Biol Inorg Chem 27, 553–564 (2022). https://doi.org/10.1007/s00775-022-01946-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-022-01946-3